A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo.

"Declarations Ethical approvalThe Declaration of Helsinki was strictly followed throughout the course of this investigation. This study was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University (ID: PJ-KS-KY-2022-60). Consent to participateAll authors engaged in this work willingly and consented to its publication. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding The research was conducted with support from the Leading Talent Team of Support Program for High Level Talent's Innovation of Dalian in 2019 (2019RD11), the Key Projects of Overseas Training Foundation of the Higher Education Institutions of Liaoning Province, China (2020GJWZD004), and the National Natural Science Foundation of China (No. 82000075)."